Sequential use of Romosozumab-Zoledronate May Increase risk of MRONJ: Study

Researchers have found in a new study that sequential use of romosozumab followed by zoledronate may heighten the risk of medication-related osteonecrosis of the jaw (MRONJ), highlighting the need for...